Bright Minds Biosciences Inc.

NASDAQ (USD): Bright Minds Biosciences Inc. (DRUG)

Last Price

11.90

Today's Change

+9.41 (378.19%)

Day's Change

2.49 - 17.12

Trading Volume

64,987,682

Overview

Market Cap

52 Million

Shares Outstanding

4 Million

Avg Volume

432,596

Avg Price (50 Days)

1.16

Avg Price (200 Days)

1.33

PE Ratio

-18.50

EPS

-0.64

Earnings Announcement

27-Nov-2024

Previous Close

2.49

Open

2.62

Day's Range

2.49 - 17.1199

Year Range

0.93 - 17.1199

Trading Volume

65,031,902

Price Change Highlight

1 Day Change

367.22%

5 Day Change

1012.74%

1 Month Change

828.74%

3 Month Change

1056.37%

6 Month Change

858.94%

Ytd Change

541.03%

1 Year Change

646.52%

3 Year Change

-68.25%

5 Year Change

-56.31%

10 Year Change

-56.31%

Max Change

-56.31%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment